Cargando…

Advances in Alzheimer's imaging are changing the experience of Alzheimer's disease

Neuroimaging is advancing a new definition of Alzheimer's disease (AD). Using imaging biomarkers, clinicians may begin to diagnose the disease by identifying pathology and neurodegeneration in either cognitively impaired or unimpaired adults. This “biomarker-based” diagnosis may allow clinician...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stites, Shana D., Milne, Richard, Karlawish, Jason
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Special Section: State of the Field: Advances in Neuroimaging from the 2017 Alzheimer’s Imaging Consortium. (Guest Editors: Drs. David Wolk, Victor Villemagne & Bradford Dickerson)
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5956938/ https://www.ncbi.nlm.nih.gov/pubmed/29780873 http://dx.doi.org/10.1016/j.dadm.2018.02.006

Ejemplares similares

Similar pattern of atrophy in early- and late-onset Alzheimer's disease
por: Eckerström, Carl, et al.
Publicado: (2018)

The personalized Alzheimer's disease cortical thickness index predicts likely pathology and clinical progression in mild cognitive impairment
por: Racine, Annie M., et al.
Publicado: (2018)

Regional tract-specific white matter hyperintensities are associated with patterns of aging-related brain atrophy via vascular risk factors, but also independently
por: Habes, Mohamad, et al.
Publicado: (2018)

Topographic staging of tau positron emission tomography images
por: Schwarz, Adam J., et al.
Publicado: (2018)

Elevated medial temporal lobe and pervasive brain tau-PET signal in normal participants
por: Lowe, Val J., et al.
Publicado: (2018)

Tau positron emission tomography imaging in tauopathies: The added hurdle of off-target binding
por: Lemoine, Laetitia, et al.
Publicado: (2018)

Cross-sectional and longitudinal atrophy is preferentially associated with tau rather than amyloid β positron emission tomography pathology
por: Gordon, Brian A., et al.
Publicado: (2018)

Molecular imaging: What is right and what is an illusion?
por: Klunk, William E.
Publicado: (2018)

Neuropsychology and neuroimaging profiles of amyloid-positive versus amyloid-negative amnestic mild cognitive impairment patients
por: Tomadesso, Clémence, et al.
Publicado: (2018)

A robust biomarker of large-scale network failure in Alzheimer's disease
por: Wiepert, Daniela A., et al.
Publicado: (2017)

Alzheimer's disease: The influence of age on clinical heterogeneity through the human brain connectome
por: Dickerson, Bradford C., et al.
Publicado: (2016)

Cognitive complaints in older adults at risk for Alzheimer's disease are associated with altered resting-state networks
por: Contreras, Joey A., et al.
Publicado: (2016)

A comparison of measurement methods of hippocampal atrophy rate for predicting Alzheimer's dementia in the Aberdeen Birth Cohort of 1936
por: Rana, Arnab K., et al.
Publicado: (2016)

The APOE ε4 genotype modulates CSF YKL-40 levels and their structural brain correlates in the continuum of Alzheimer's disease but not those of sTREM2
por: Gispert, Juan Domingo, et al.
Publicado: (2016)

Association between Aβ and tau accumulations and their influence on clinical features in aging and Alzheimer's disease spectrum brains: A [(11)C]PBB3-PET study
por: Shimada, Hitoshi, et al.
Publicado: (2016)

Tau-PET uptake: Regional variation in average SUVR and impact of amyloid deposition
por: Vemuri, Prashanthi, et al.
Publicado: (2016)

Trends in the incidence of dementia: design and methods in the Alzheimer Cohorts Consortium
por: Chibnik, Lori B., et al.
Publicado: (2017)

The Early Growth Genetics (EGG) and EArly Genetics and Lifecourse Epidemiology (EAGLE) consortia: design, results and future prospects
por: Middeldorp, Christel M., et al.
Publicado: (2019)

Microbleeds are associated with depressive symptoms in Alzheimer's disease
por: Leeuwis, Anna E., et al.
Publicado: (2017)

Convivir con Alzheimer /
por: Matías-Guiu Guía, Jordi
Publicado: (2004)

Enfermedad de Alzheimer
Publicado: (1990)

Impaired perfusion and capillary dysfunction in prodromal Alzheimer's disease
por: Nielsen, Rune B., et al.
Publicado: (2020)

Macrovascular and microvascular cerebral blood flow in adults at risk for Alzheimer's disease
por: Clark, Lindsay R., et al.
Publicado: (2017)

Degradation in intrinsic connectivity networks across the Alzheimer's disease spectrum
por: Nuttall, Rachel, et al.
Publicado: (2016)

Early affective changes and increased connectivity in preclinical Alzheimer's disease
por: Fredericks, Carolyn A., et al.
Publicado: (2018)

In vivo coupling of tau pathology and cortical thinning in Alzheimer's disease
por: Mak, Elijah, et al.
Publicado: (2018)

Prediction of Alzheimer's disease pathophysiology based on cortical thickness patterns
por: Hwang, Jihye, et al.
Publicado: (2015)

Pathobiology of Alzheimer's disease /
Publicado: (1995)

Atrophy of presubiculum and subiculum is the earliest hippocampal anatomical marker of Alzheimer's disease
por: Carlesimo, Giovanni A., et al.
Publicado: (2015)

Amyloid-related imaging abnormalities from trials of solanezumab for Alzheimer's disease
por: Carlson, Christopher, et al.
Publicado: (2016)

Structural connectivity centrality changes mark the path toward Alzheimer's disease
por: Peraza, Luis R., et al.
Publicado: (2019)

Utility of perfusion PET measures to assess neuronal injury in Alzheimer's disease
por: Joseph-Mathurin, Nelly, et al.
Publicado: (2018)

Brain amyloid in preclinical Alzheimer's disease is associated with increased driving risk
por: Ott, Brian R., et al.
Publicado: (2016)

Nonparenchymal fluid is the source of increased mean diffusivity in preclinical Alzheimer's disease
por: Sepehrband, Farshid, et al.
Publicado: (2019)

Nutritional status and structural brain changes in Alzheimer's disease: The NUDAD project
por: Verhaar, Barbara J.H., et al.
Publicado: (2020)

Association between neurite metrics and tau/inflammatory pathology in Alzheimer's disease
por: Sone, Daichi, et al.
Publicado: (2020)

Deep learning improves utility of tau PET in the study of Alzheimer's disease
por: Zou, James, et al.
Publicado: (2021)

Physical activity and prevention of Alzheimer's disease
por: Li, Rena, et al.
Publicado: (2016)

Serum IL-8 is a marker of white-matter hyperintensities in patients with Alzheimer's disease
por: Zhu, Yanan, et al.
Publicado: (2017)

Enfermedad de Alzheimer : una guía para la familia /
por: Powell, Lenore S.
Publicado: (1988)

Cannot write session to /tmp/vufind_sessions/sess_gsdk71u2b7m8m2c71sb4gov6me